# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-24-010416
Filing Date
2024-04-01
Accepted
2024-04-01 17:20:48
Documents
96
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-K | omer20231231_10k.htm iXBRL | 10-K | 1842138
2 | EXHIBIT 10.23 | ex_630463.htm | EX-10.23 | 214392
3 | EXHIBIT 10.24 | ex_630464.htm | EX-10.24 | 54513
4 | EXHIBIT 10.25 | ex_630465.htm | EX-10.25 | 68856
5 | EXHIBIT 10.30 | ex_630468.htm | EX-10.30 | 354336
6 | EXHIBIT 23.1 | ex_566808.htm | EX-23.1 | 3397
7 | EXHIBIT 31.1 | ex_566809.htm | EX-31.1 | 8629
8 | EXHIBIT 31.2 | ex_566810.htm | EX-31.2 | 8629
9 | EXHIBIT 32.1 | ex_566811.htm | EX-32.1 | 5272
10 | EXHIBIT 32.2 | ex_566812.htm | EX-32.2 | 5310
11 | EXHIBIT 97.1 | ex_630461.htm | EX-97.1 | 29383
17 |  | stockpricegraph.jpg | GRAPHIC | 40037
| Complete submission text file | 0001437749-24-010416.txt |  | 9867090

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
12 | XBRL TAXONOMY EXTENSION SCHEMA | omer-20231231.xsd | EX-101.SCH | 82576
13 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | omer-20231231_cal.xml | EX-101.CAL | 77094
14 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | omer-20231231_def.xml | EX-101.DEF | 554337
15 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | omer-20231231_lab.xml | EX-101.LAB | 480603
16 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | omer-20231231_pre.xml | EX-101.PRE | 588398
100 | EXTRACTED XBRL INSTANCE DOCUMENT | omer20231231_10k_htm.xml | XML | 1434479

Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 206-676-5000
OMEROS CORP (Filer) CIK: 0001285819 (see all company filings)

EIN.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34475 | Film No.: 24811018
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)